Identifier
Created
Classification
Origin
07TOKYO4579
2007-10-01 05:22:00
UNCLASSIFIED
Embassy Tokyo
Cable title:
JAPAN AVIAN INFLUENZA UPDATE
VZCZCXRO2813 PP RUEHHM RUEHLN RUEHMA RUEHPB RUEHPOD DE RUEHKO #4579 2740522 ZNR UUUUU ZZH P 010522Z OCT 07 FM AMEMBASSY TOKYO TO RUEHC/SECSTATE WASHDC PRIORITY 8113 INFO RUEHZN/ENVIRONMENT SCIENCE AND TECHNOLOGY COLLECTIVE RUEHJA/AMEMBASSY JAKARTA 4295 RUEHHI/AMEMBASSY HANOI 1027 RUEHBJ/AMEMBASSY BEIJING 9259 RUEHFK/AMCONSUL FUKUOKA 3457 RUEHNAG/AMCONSUL NAGOYA 2393 RUEHNH/AMCONSUL NAHA 5870 RUEHOK/AMCONSUL OSAKA KOBE 7115 RUEHKSO/AMCONSUL SAPPORO 4177 RUEHRC/USDA FAS WASHDC 8552 RUEAUSA/DEPT OF HHS WASHINGTON DC RUEAIIA/CIA WASHDC
UNCLAS TOKYO 004579
SIPDIS
DEPT FOR AIAG AMBASSADOR LANGE
DEPT FOR OES/IHA COMELLA
DEPT FOR EAP/J
USDA PASS TO APHIS
HHS PASS TO CDC
HHS FOR OGHA STEIGER AND HICKEY
DEPT PASS TO AID/GH/HIDN DENNIS CARROLL
SIPDIS
E.O. 12958: N/A
TAGS: TBIO KFLU KSTH ECON PREL SOCI CASC JA
SUBJECT: JAPAN AVIAN INFLUENZA UPDATE
REF: A. 05 STATE 153802
B. TOKYO 2394 AND PREVIOUS
C. 06 TOKYO 2135
UNCLAS TOKYO 004579
SIPDIS
DEPT FOR AIAG AMBASSADOR LANGE
DEPT FOR OES/IHA COMELLA
DEPT FOR EAP/J
USDA PASS TO APHIS
HHS PASS TO CDC
HHS FOR OGHA STEIGER AND HICKEY
DEPT PASS TO AID/GH/HIDN DENNIS CARROLL
SIPDIS
E.O. 12958: N/A
TAGS: TBIO KFLU KSTH ECON PREL SOCI CASC JA
SUBJECT: JAPAN AVIAN INFLUENZA UPDATE
REF: A. 05 STATE 153802
B. TOKYO 2394 AND PREVIOUS
C. 06 TOKYO 2135
1. No human or animal outbreaks of H5N1 Avian Influenza (AI) were
reported in Japan during the period from May 24 to September 27.
MHLW to Approve Sale of New H5N1 Vaccine for Humans
2. An advisory panel to the Ministry of Health, Labor and Welfare
(MHLW) on September 1 confirmed the safety and effectiveness of a
new H5N1 vaccine developed by Japanese researchers in cooperation
with Japan's National Institute of Infectious Diseases. The MHLW
Minister is expected, acting on the panel's conclusion, to approve
the production and sale of the new vaccine by the end of 2007. It
will be the first human AI vaccine coming from Japanese research
institutes and was developed by the Kitasato Research Institute and
the Research Foundation for Microbial Diseases of Osaka University
using an H5N1 virus from a human case in Vietnam. Once in
production, the vaccine will be stockpiled by the GOJ as a
pre-pandemic vaccine. The MHLW is also promoting the development of
additional vaccines using H5N1 viruses obtained from cases in
Indonesia and China.
GOJ Announces AI Assistance to Indonesia
3. The GOJ has announced that it will donate up to 1.78 billion yen
(USD 15.5 million) in bilateral aid to Indonesia for improving
animal health laboratory capabilities for diagnosing AI and other
animal diseases. According to Japan's Ministry of Foreign Affairs,
Japanese and Indonesian officials exchanged letters on the project
on September 13, following an announcement by then PM Abe during his
August visit to Indonesia. Implemented by the Indonesian Ministry
of Agriculture, the project aims to improve diagnostic capabilities
at an animal diagnosis center in Java and two such centers in
Sumatra by upgrading facilities to BSL2+ and BSL3 and doubling lab
capacity.
DONOVAN
SIPDIS
DEPT FOR AIAG AMBASSADOR LANGE
DEPT FOR OES/IHA COMELLA
DEPT FOR EAP/J
USDA PASS TO APHIS
HHS PASS TO CDC
HHS FOR OGHA STEIGER AND HICKEY
DEPT PASS TO AID/GH/HIDN DENNIS CARROLL
SIPDIS
E.O. 12958: N/A
TAGS: TBIO KFLU KSTH ECON PREL SOCI CASC JA
SUBJECT: JAPAN AVIAN INFLUENZA UPDATE
REF: A. 05 STATE 153802
B. TOKYO 2394 AND PREVIOUS
C. 06 TOKYO 2135
1. No human or animal outbreaks of H5N1 Avian Influenza (AI) were
reported in Japan during the period from May 24 to September 27.
MHLW to Approve Sale of New H5N1 Vaccine for Humans
2. An advisory panel to the Ministry of Health, Labor and Welfare
(MHLW) on September 1 confirmed the safety and effectiveness of a
new H5N1 vaccine developed by Japanese researchers in cooperation
with Japan's National Institute of Infectious Diseases. The MHLW
Minister is expected, acting on the panel's conclusion, to approve
the production and sale of the new vaccine by the end of 2007. It
will be the first human AI vaccine coming from Japanese research
institutes and was developed by the Kitasato Research Institute and
the Research Foundation for Microbial Diseases of Osaka University
using an H5N1 virus from a human case in Vietnam. Once in
production, the vaccine will be stockpiled by the GOJ as a
pre-pandemic vaccine. The MHLW is also promoting the development of
additional vaccines using H5N1 viruses obtained from cases in
Indonesia and China.
GOJ Announces AI Assistance to Indonesia
3. The GOJ has announced that it will donate up to 1.78 billion yen
(USD 15.5 million) in bilateral aid to Indonesia for improving
animal health laboratory capabilities for diagnosing AI and other
animal diseases. According to Japan's Ministry of Foreign Affairs,
Japanese and Indonesian officials exchanged letters on the project
on September 13, following an announcement by then PM Abe during his
August visit to Indonesia. Implemented by the Indonesian Ministry
of Agriculture, the project aims to improve diagnostic capabilities
at an animal diagnosis center in Java and two such centers in
Sumatra by upgrading facilities to BSL2+ and BSL3 and doubling lab
capacity.
DONOVAN